Brand profile · Biotechnology Research

Carina Biotech

Carina Biotech works in Biotechnology Research, out of Adelaide, South Australia. Ownership is privately held; it publishes at carinabiotech.com. It holds one address on record, all in Australia. The record counts 17 people. Tagged science, research & development and biotechnology. One Australian registration (ABN) is a confirmed match. The latest round on record is Series unknown at US$7.5M. The record links nine similar brands, most of them in Biotechnology Research.

Profile live Privately Held Founded 2016 1 entity ABN 1 office country US$ 7.5M Series unknown
Registry verified · ABR

Key facts

Counted staff
17
self-reported 2–10 band
Founded
2016
10 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
1
Series unknown · Sep 2023 · US$ 7.5M
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity
  • CARINA BIOTECH LIMITED

    ABN43613276074

    SAHigh confidenceMatched on exact nameABR

Legal entities

Carina Biotech: 1 registry entityCarina Biotech is linked to 1 registry entity: CARINA BIOTECH LIMITED (ABN 43613276074, candidate).Carina BiotechCARINA BIOTECH LIMITEDABN 43613276074Candidate · High confidence
Show as table · Carina Biotech: 1 registry entity
Carina Biotech: 1 registry entity
CARINA BIOTECH LIMITEDABN 43613276074
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Carina Biotech

An Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. Carina are working towards producing broad-spectrum CAR-T therapies that can be used to treat multiple solid cancers yet are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing.

We are working to…

1. Expand the clinical indications for T cell therapies

2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable

Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Women's & Children's Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Children's Hospital in the United States.

Specialties

All 8 specialties
  • CAR-T cells
  • immunotherapy
  • T cell biology
  • cancer biology
  • biomaterials
  • research & development
  • biotechnology
  • science

Related specialties

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AULevel 5, Catherine Helen Spence Building, UniSA City West Campus; Adelaide , South Australia 5000Primary

Grid intelligence Members

Funding

Last round · 15 September 2023US$ 7.5MSeries unknown
Rounds1
Round typeSeries unknown · venture round
Amount (USD)7,500,000
Stage ranknot recorded
Investors named0
Since last round2 yr 4 mo

Funding

1 funding roundFunding timeline. Latest round 15 Sep 2023: Series unknown, US$ 7.5M.20162026Series unknownUS$ 7.5M1 round
Show as table · 1 funding round
1 funding round
Rounds1
Axis2016 to 2026
Series unknown · 15 Sep 2023US$ 7.5M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Carina Biotech?

One South Australia entity on the ABR. CARINA BIOTECH LIMITED (ABN 43 613 276 074), high confidence.

How many people work at Carina Biotech?

The record holds 17 counted staff profiles at January 2026, above the self-reported 2–10 band.

Where does Carina Biotech have offices?

One address on record, Australia only. Primary: Level 5, Catherine Helen Spence Building, UniSA City West Campus, Adelaide, South Australia 5000.

Has Carina Biotech raised funding?

One round. Latest 15 September 2023: Series unknown, US$7,500,000.

What does Carina Biotech list as its specialties?

Eight tags on the brand's own list, among them science, research & development and biotechnology.

Which companies are listed alongside Carina Biotech?

33 profiles list Carina Biotech as a peer — 97th percentile in Biotechnology Research. It lists ten peers of its own. Prescient Therapeutics and Imugene Limited list it back.

What is Carina Biotech's website?